Mikkael Lamoca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mikkael Lamoca has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Karin Wuertz-Kozak
Department of Biomedical Engineering Rochester Institute of Technology Rochester New York USA
2 shared publications - Andrea De Pieri
Regenerative, Modular & Developmental Engineering Laboratory (REMODEL), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, Ireland; Science Foundation Ireland (SFI) Centre for Research in Medical Devices (CÚRAM), Biomedical Sciences Building, National University of Ireland Galway (NUI Galway), Galway, Ireland; Proxy Biomedical Ltd., Spiddal, Galway, Ireland
1 shared publication - Benjamin Gantenbein
Tissue Engineering for Orthopaedics & Mechanobiology, Bone & Joint Program, Department for BioMedical Research (DBMR), Medical Faculty University of Bern Bern Switzerland
1 shared publication - Christopher L. Lewis
Department of Manufacturing and Mechanical Engineering Technology, Rochester Institute of Technology, Rochester, NY 14623, USA
1 shared publication - Daniel Farchione
Inamori School of Engineering, Alfred University, Alfred, NY 14802, USA
1 shared publication - Emily Lazarus
OcuCell Inc, Baltimore, MD, United States of America
1 shared publication
Latest Publications
- Open Access
- 13 October 2025
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 11 (4)
Potential of low‐field MRI for increasing participation of Filipino Americans and underrepresented populations in Alzheimer's and dementia research
INTRODUCTION: Lack of racial and ethnic minority representation in Alzheimer's disease and related dementias (ADRD) research studies leads to inaccurate trial results and health outcomes disparities. This study examines barriers to ADRD research participation in under‐studied Filipino American participants and explores the potential of low‐field magnetic resonance imaging (LF‐MRI) to mitigate these barriers. METHODS: We utilized GIS mapping to analyze demographic differences across geographic distances from Alzheimer's Disease Research Centers (ADRCs) in the United States. The number of visits in racial and ethnic minority populations was examined using regression analysis of participant data from the National Alzheimer's Coordinating Center (NACC). Surveys and interviews were conducted with researchers and participants from the University of California, San Francisco Memory and Aging Center to identify barriers and explore LF‐MRI's potential to increase Filipino American participation. We conclude with recommendations for LF‐MRI implementation in ADRD research. RESULTS: Location‐based analysis demonstrates that LF‐MRI may help diversify ADRD research participation by offering portable, cheap imaging modalities in satellite locations. Moreover, many racial and ethnic minority populations, particularly Asians, are underrepresented and less likely to have multiple ADRC visits compared to non‐Hispanic and White individuals. Interviews and surveys identified participation barriers, including navigation, scheduling, fear of MRI, health‐related stigma, and discomfort with conventional MRI procedures. It also suggested that LF‐MRI may offer increased portability, reduced costs, improved physical comfort, and less anxiety. Additionally, researchers identified barriers to implementation, including lack of efficacy and reliability data for advanced imaging requirements, and logistical, privacy, and staff bandwidth concerns. DISCUSSION: These findings contribute to improved understanding of clinical research participation barriers among racial and ethnic minority populations. LF‐MRI implementation was explored as a potential way to mitigate these barriers. Future research should address scientific and infrastructural limitations and explore ways to leverage the benefits of LF‐MRI in advancing diversity in ADRD research. Highlights: Racial and ethnic minorities in Alzheimer's disease and related dementias (ADRD) research are underrepresented, including Asians. Expanding ADRD research access for Asian and minority groups needs broader outreach. Many minority populations are located beyond the typical travel distance from Alzheimer's Disease Research Centers (ADRCs). low‐field magnetic resonance imaging (LF‐MRI) may address comfort, cost, accessibility, and geographical barriers. LF‐MRI implementation may lead to an increase in research participation.
- 13 October 2025
- Published by Wiley in Alzheimer's & Dementia: Translational Research & Clinical Interventions
- Vol. 11 (4)
Open AccessPotential of low‐field MRI for increasing participation of Filipino Americans and underrepresented populations in Alzheimer's and dementia research
INTRODUCTION: Lack of racial and ethnic minority representation in Alzheimer's disease and related dementias (ADRD) research studies leads to inaccurate trial results and health outcomes disparities. This study examines barriers to ADRD research participation in under‐studied Filipino American participants and explores the potential of low‐field magnetic resonance imaging (LF‐MRI) to mitigate these barriers. METHODS: We utilized GIS mapping to analyze demographic differences across geographic distances from Alzheimer's Disease Research Centers (ADRCs) in the United States. The number of visits in racial and ethnic minority populations was examined using regression analysis of participant data from the National Alzheimer's Coordinating Center (NACC). Surveys and interviews were conducted with researchers and participants from the University of California, San Francisco Memory and Aging Center to identify barriers and explore LF‐MRI's potential to increase Filipino American participation. We conclude with recommendations for LF‐MRI implementation in ADRD research. RESULTS: Location‐based analysis demonstrates that LF‐MRI may help diversify ADRD research participation by offering portable, cheap imaging modalities in satellite locations. Moreover, many racial and ethnic minority populations, particularly Asians, are underrepresented and less likely to have multiple ADRC visits compared to non‐Hispanic and White individuals. Interviews and surveys identified participation barriers, including navigation, scheduling, fear of MRI, health‐related stigma, and discomfort with conventional MRI procedures. It also suggested that LF‐MRI may offer increased portability, reduced costs, improved physical comfort, and less anxiety. Additionally, researchers identified barriers to implementation, including lack of efficacy and reliability data for advanced imaging requirements, and logistical, privacy, and staff bandwidth concerns. DISCUSSION: These findings contribute to improved understanding of clinical research participation barriers among racial and ethnic minority populations. LF‐MRI implementation was explored as a potential way to mitigate these barriers. Future research should address scientific and infrastructural limitations and explore ways to leverage the benefits of LF‐MRI in advancing diversity in ADRD research. Highlights: Racial and ethnic minorities in Alzheimer's disease and related dementias (ADRD) research are underrepresented, including Asians. Expanding ADRD research access for Asian and minority groups needs broader outreach. Many minority populations are located beyond the typical travel distance from Alzheimer's Disease Research Centers (ADRCs). low‐field magnetic resonance imaging (LF‐MRI) may address comfort, cost, accessibility, and geographical barriers. LF‐MRI implementation may lead to an increase in research participation.
- Open Access
- 13 April 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (4) , 853
Resveratrol Microencapsulation into Electrosprayed Polymeric Carriers for the Treatment of Chronic, Non-Healing Wounds
Chronic, non-healing wounds represent a challenging socio-economic burden, demanding innovative approaches for successful wound management. Resveratrol (RSV) represents a promising therapeutic candidate, but its therapeutic efficacy and clinical applicability have been hampered by its rapid degradation and/or depletion. Herein, RSV was encapsulated into poly(ε-caprolactone) (PCL) microparticles by electrospraying with the aim to prolong and preserve RSV’s release/activity, without affecting its therapeutic properties. Electrospraying led to the fabrication of spherical (2 to 10 μm in size), negatively charged (<−1 mV), and quasi-monodisperse (PDI < 0.3) microparticles, with 60% RSV release after 28 days. Microencapsulation of RSV into PCL prevented its photochemical degradation and preserved its antioxidant properties over 72 h. The RSV-PCL microparticles did not exhibit any cytotoxicity on human dermal fibroblasts. RSV released from the microparticles was biologically functional and induced a significant increase in collagen type I deposition. Furthermore, the produced RSV-PCL microparticles reduced the expression of inflammatory (IL-6, IL-8, COX-2) and proteolytic (MMP-2, MMP-9) mediators. Collectively, our data clearly illustrate the potential of electrosprayed polymeric carriers for the sustained delivery of RSV to treat chronic wounds.
- 13 April 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (4) , 853
Open AccessResveratrol Microencapsulation into Electrosprayed Polymeric Carriers for the Treatment of Chronic, Non-Healing Wounds
Chronic, non-healing wounds represent a challenging socio-economic burden, demanding innovative approaches for successful wound management. Resveratrol (RSV) represents a promising therapeutic candidate, but its therapeutic efficacy and clinical applicability have been hampered by its rapid degradation and/or depletion. Herein, RSV was encapsulated into poly(ε-caprolactone) (PCL) microparticles by electrospraying with the aim to prolong and preserve RSV’s release/activity, without affecting its therapeutic properties. Electrospraying led to the fabrication of spherical (2 to 10 μm in size), negatively charged (<−1 mV), and quasi-monodisperse (PDI < 0.3) microparticles, with 60% RSV release after 28 days. Microencapsulation of RSV into PCL prevented its photochemical degradation and preserved its antioxidant properties over 72 h. The RSV-PCL microparticles did not exhibit any cytotoxicity on human dermal fibroblasts. RSV released from the microparticles was biologically functional and induced a significant increase in collagen type I deposition. Furthermore, the produced RSV-PCL microparticles reduced the expression of inflammatory (IL-6, IL-8, COX-2) and proteolytic (MMP-2, MMP-9) mediators. Collectively, our data clearly illustrate the potential of electrosprayed polymeric carriers for the sustained delivery of RSV to treat chronic wounds.
- Open Access
Sulfated Hydrogels in Intervertebral Disc and Cartilage Research
Hydrogels are commonly used for the 3D culture of musculoskeletal cells. Sulfated hydrogels, which have seen a growing interest over the past years, provide a microenvironment that help maintain the phenotype of chondrocytes and chondrocyte-like cells and can be used for sustained delivery of growth factors and other drugs. Sulfated hydrogels are hence valuable tools to improve cartilage and intervertebral disc tissue engineering. To further advance the utilization of these hydrogels, we identify and summarize the current knowledge about different sulfated hydrogels, highlight their beneficial effects in cartilage and disc research, and review the biofabrication processes most suitable to secure best quality assurance through deposition fidelity, repeatability, and attainment of biocompatible morphologies.
Open AccessSulfated Hydrogels in Intervertebral Disc and Cartilage Research
Hydrogels are commonly used for the 3D culture of musculoskeletal cells. Sulfated hydrogels, which have seen a growing interest over the past years, provide a microenvironment that help maintain the phenotype of chondrocytes and chondrocyte-like cells and can be used for sustained delivery of growth factors and other drugs. Sulfated hydrogels are hence valuable tools to improve cartilage and intervertebral disc tissue engineering. To further advance the utilization of these hydrogels, we identify and summarize the current knowledge about different sulfated hydrogels, highlight their beneficial effects in cartilage and disc research, and review the biofabrication processes most suitable to secure best quality assurance through deposition fidelity, repeatability, and attainment of biocompatible morphologies.